About Renocrit 4000
- Product Name: Renocrit 4000 IU Injection
- Composition: Recombinant Human Erythropoietin 4000 IU
- Form: Injectable solution
- Type: Prescription-only
- Packaging: Vial
- Manufacturer: Zydus
- Use: Supports anemia management in CKD and related conditions
Ending Soon-secure your Recombinant Human Erythropoietin Injection IP 4000 IU at an Unbeatable Price! This outstanding hematopoietic agent comes as a clear, colorless solution in a preservative-free, pre-filled syringe (4000 IU/0.4 mL). Engineered for elite therapeutic performance, it stimulates red blood cell production to treat anemia linked to chronic renal failure, chemotherapy, or HIV therapy. Imposing shelf life of 24 months. Suitable for adults and supplied in robust packaging. Prescription only. Store refrigerated. Fresh stock-origin India. Do not miss this elite medical solution!
Elite Application Areas and Defining Features
Recombinant Human Erthropoietin Injection IP 4000 IU is ideally used in hospitals, clinics, and specialized treatment centers. Its outstanding characteristics include a preservative-free formulation, clear appearance, and suitability for both subcutaneous and intravenous administration. Specifically designed for anemia resulting from chronic kidney disease, chemotherapy, or HIV therapy, it provides targeted, effective stimulation of red blood cell production as directed by physicians. The pre-filled syringe ensures precise, convenient dosing, tailored for adult patients needing reliable, fast-acting hematopoietic therapy.
Certifications, Sample Options, and Packaging Excellence
With an imposing market value in the pharmaceutical sector, Recombinant Human Erthropoietin Injection IP 4000 IU meets rigorous certification standards for quality and safety. Samples are available upon request, facilitating product trials before broader adoption. Packaging provides robust protection through blister packing within a box, ensuring safe transport and optimal storage during transportation. Each box contains one freshly pre-filled syringe, with transport services conforming to strict refrigeration requirements, maintaining medication integrity from supplier to end-user.
FAQ's of Recombinant Human Erthropoietin Injection IP 4000 IU:
Q: How should Recombinant Human Erthropoietin Injection IP 4000 IU be administered?
A: This injection is typically administered either subcutaneously or intravenously, as directed by a qualified physician, to ensure optimal absorption and effectiveness.
Q: What specific conditions is this injection recommended for?
A: It is indicated for the treatment of anemia associated with chronic kidney disease, cancer chemotherapy, or HIV therapy in adult patients.
Q: Where should the injection be stored to preserve its effectiveness?
A: The pre-filled syringe should be stored refrigerated between 2C to 8C, protected from light, and must not be frozen to maintain its therapeutic quality.
Q: When should this injection be avoided?
A: This medication should not be used in patients with uncontrolled hypertension or those who have shown hypersensitivity to erythropoietin or any excipients in the formulation.
Q: What are the benefits of the preservative-free formulation?
A: A preservative-free formulation reduces the risk of allergic reactions and irritation, making it safer for sensitive patients and providing greater compatibility for repeated administration.